P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION

P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION

Introduction: Post-transplant renal dysfunction (RD) in Liver transplantation occurs 18% at 5 years, mainly due to calcineurin inhibitors (13 to 33%). Nephroprotective strategies include minimization and / or suspension of CNI or conversion to mTOR (everolimus). Objectives: To evaluate the experienc...

Full description

Bibliographic Details
Main Authors: Carolina Salinas, Katherine Marrugo, Martin Garzón, Leonardo Perez, Oscar Beltran, Geovanny Hernandez, Islena Blanco, Jairo Rivera, Adriana Varon, Gilberto Mejia
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268121001617

Internet

http://www.sciencedirect.com/science/article/pii/S1665268121001617

Similar Items